BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Allergy to pollen, Kidney, Pharmacogenetics, Doxycycline, rs2230926, FABP1)
Bookmark Forward

QuickView for CDKN2A (gene)


Body Atlas

Most Correlated Tissues

  1. Plasma cell of spleen
  2. Parotid gland
  3. Skeletal muscle psoas
  4. Microglial cell
  5. Ascending colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Papilloma virus
  2. Human papilloma virus infection
  3. Skin cancer
  4. Uterine cancer
  5. Drug resistance
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. AMI-1 compound
  2. Lincomycin
  3. oxaprozin
  4. sodium selenate
  5. pyridine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. NR5A1
  2. BMPR2
  3. RHOC
  4. AARS
  5. CDKN1B
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The ARF GTPase regulatory network in collective invasion and metastasis.
  2. TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcom…
  3. STED imaging of endogenously tagged ARF GTPases reveals their distinct nanoscale localizations.
  4. TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
  5. The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
  2. Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Can…
  3. Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelat…
  4. Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperativ…
  5. Pilot Study of Abemaciclib With Bevacizumab in Recurrent Glioblastoma Patients With Loss of CDKN2A/B…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.